[1]谢 丹.不同促排卵方案治疗多囊卵巢综合征不孕症的效果[J].医学信息,2020,33(18):141-142.[doi:10.3969/j.issn.1006-1959.2020.18.046]
　XIE Dan.The Effect of Different Ovulation Induction Programs on the Infertility of Polycystic Ovary Syndrome[J].Medical Information,2020,33(18):141-142.[doi:10.3969/j.issn.1006-1959.2020.18.046]
点击复制

不同促排卵方案治疗多囊卵巢综合征不孕症的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年18期
页码:
141-142
栏目:
药物与临床
出版日期:
2020-09-15

文章信息/Info

Title:
The Effect of Different Ovulation Induction Programs on the Infertility of Polycystic Ovary Syndrome
文章编号:
1006-1959（2020）18-0141-02
作者:
谢 丹
（浙江省嘉兴市悦程妇产医院妇产科，浙江 嘉兴 314000）
Author(s):
XIE Dan
(Department of Obstetrics and Gynecology,Yuecheng Obstetrics and Gynecology Hospital,Jiaxing 314000,Zhejiang,China)
关键词:
促排卵; 多囊卵巢综合征; 不孕症
Keywords:
Ovulation induction; Polycystic ovary syndrome; Infertility
分类号:
R711.6
DOI:
10.3969/j.issn.1006-1959.2020.18.046
文献标志码:
A
摘要:
目的 观察不同促排卵方案对多囊卵巢综合征不孕症患者治疗效果。方法 选择2018年6月~2019年6月在我院治疗的60例多囊卵巢综合征不孕症患者，随机分为对照组和实验组，各30例。对照组采用人绝经期促性腺激素治疗，实验组在对照组基础上联合应用氯米芬治疗，比较两组临床排卵率、妊娠率、雌二醇水平、黄体生成素水平、子宫内膜厚度、成熟卵泡数及不良反应发生率。结果 实验组排卵率（86.67%）、妊娠率（36.67%）分别高于对照组的63.33%、16.67%（P＜0.05）；实验组雌二醇、黄体生成素水平、子宫内膜厚度、成熟卵泡数均高于对照组（P＜0.05）；实验组不良反应发生率为6.67%，低于对照组的26.67%（P＜0.05）。结论 人绝经期促性腺激素联合氯米芬治疗多囊卵巢综合征不孕症疗效较好，改善排卵障碍优于单用人绝经期促性腺激素，有助于提高妊娠率，且临床不良反应发生率低，安全可行。
Abstract:
Objective To observe the effects of different ovulation induction programs on infertility patients with polycystic ovary syndrome.Methods A total of 60 infertility patients with polycystic ovary syndrome who were treated in our hospital from June 2018 to June 2019 were selected and randomly divided into a control group and an experimental group, with 30 cases in each group. The control group was treated with human menopausal gonadotropin, and the experimental group was combined with clomiphene treatment on the basis of the control group. The clinical ovulation rate, pregnancy rate, estradiol level, luteinizing hormone level, endometrial thickness, The number of mature follicles and the incidence of adverse reactions.Results The ovulation rate (86.67%) and pregnancy rate (36.67%) of the experimental group were higher than those of the control group, 63.33% and 16.67% respectively(P＜0.05); the levels of estradiol and luteinizing hormone in the experimental group endometrial thickness and the number of mature follicles were higher than those of the control group (P＜0.05); the adverse reaction rate of the experimental group was 6.67%, which was lower than 26.67% of the control group(P＜0.05).Conclusion The combination of human menopausal gonadotropin combined with clomiphene in the treatment of infertility with polycystic ovary syndrome was effective, and it was better to improve ovulation disorders than using human menopausal gonadotropin alone, which could help increase pregnancy rate and the incidence of clinical adverse reactions was low, safe and feasible.

参考文献/References:

[1]张海军,杨艳艳.3种不同促排卵治疗方案对多囊卵巢综合征促排卵的疗效分析[J].中国妇幼保健,2018,33(1):156-158.[2]马玲,谢宝国,卢伟英,等.不同促排卵方案治疗高龄女性多囊卵巢综合征不孕患者的疗效分析[J].中国计划生育和妇产科,2017,9(1):42-46.[3]程周霞,柳顺玉,阮祥燕.98例多囊卵巢综合征不孕症患者多阶段促排卵治疗效果[J].安徽医学,2016,37(4):468-470.[4]吴友高.多囊卵巢综合征促排卵治疗中采用不同方法的效果比较分析[J].当代医学,2018,24(19):162-163.[5]王燕.来曲唑与尿促性素在多囊卵巢综合征不孕患者促排卵中的应用[J].医学研究杂志,2017,46(8):160-163.

相似文献/References:

[1]姜玉滢.卵泡发育及辅助生殖促排卵中促黄体生成素的作用研究[J].医学信息,2018,31(03):101.[doi:10.3969/j.issn.1006-1959.2018.03.032]
　JIANG Yu-ying.Study on the Role of Luteinizing Hormone in Ovarian Follicle Development and Assisted Reproductive Promotion of Ovulation[J].Medical Information,2018,31(18):101.[doi:10.3969/j.issn.1006-1959.2018.03.032]
[2]曾利文,陈 静,张 晔,等.多囊卵巢综合征患者的糖代谢特点分析[J].医学信息,2019,32(02):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
　ZENG Li-wen,CHEN Jing,ZHANG Ye,et al.Analysis of Characteristics of Glucose Metabolism in Patients with Polycystic Ovarian Syndrome[J].Medical Information,2019,32(18):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
[3]王海燕,毕雪玲,曹 晶,等.坤泰胶囊联合炔雌醇环丙孕酮片、二甲双胍治疗多囊卵巢综合征的效果及对性激素的影响[J].医学信息,2020,33(20):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
　WANG Hai-yan,BI Xue-ling,CAO Jing,et al.The Effect of Kuntai Capsule Combined with Ethinyl Estradiol and Cyproterone Tablets and Metformin in the Treatment of Polycystic Ovary Syndrome and Its Influence on Sex Hormones[J].Medical Information,2020,33(18):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
[4]王争艳,宋发荣.中药月经周期疗法治疗PCOS不孕症的效果[J].医学信息,2020,33(20):153.[doi:10.3969/j.issn.1006-1959.2020.20.048]
　WANG Zheng-yan,SONG Fa-rong.The Effect of Chinese Medicine Menstrual Cycle Therapy on PCOS Infertility[J].Medical Information,2020,33(18):153.[doi:10.3969/j.issn.1006-1959.2020.20.048]
[5]朱 艳,周 琴,安 洁,等.脂联素基因单核苷酸多态性与多囊卵巢综合征伴胰岛素抵抗的关系研究[J].医学信息,2020,33(22):87.[doi:10.3969/j.issn.1006-1959.2020.22.025]
　ZHU Yan,ZHOU Qin,AN Jie,et al.Study on the Relationship Between Adiponectin Gene Single Nucleotide Polymorphism and Polycystic Ovary Syndrome with Insulin Resistance[J].Medical Information,2020,33(18):87.[doi:10.3969/j.issn.1006-1959.2020.22.025]
[6]袁 瑞,余亚莉.吡格列酮二甲双胍片治疗胰岛素抵抗型多囊卵巢综合征患者的疗效[J].医学信息,2021,34(01):158.[doi:10.3969/j.issn.1006-1959.2021.01.043]
　YUAN Rui,YU Ya-li.Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets in the Treatment of Patients with Insulin-resistant Polycystic Ovary Syndrome[J].Medical Information,2021,34(18):158.[doi:10.3969/j.issn.1006-1959.2021.01.043]
[7]覃德明,曾 辛,胡雪莉.多囊卵巢综合征患者生殖道微生态状况研究[J].医学信息,2021,34(09):73.[doi:10.3969/j.issn.1006-1959.2021.09.019]
　QIN De-ming,ZENG Xin,HU Xue-li.Study on the Microecological Status of Reproductive Tract in Patients with Polycystic Ovary Syndrome[J].Medical Information,2021,34(18):73.[doi:10.3969/j.issn.1006-1959.2021.09.019]
[8]潘锦芳.多囊卵巢综合征的超声检查现状[J].医学信息,2021,34(15):39.[doi:10.3969/j.issn.1006-1959.2021.15.011]
　PAN Jin-fang.Current Status of Ultrasonography in Polycystic Ovary Syndrome[J].Medical Information,2021,34(18):39.[doi:10.3969/j.issn.1006-1959.2021.15.011]
[9]罗红财,沈 颖,黄莉珊,等.基于温肾助阳、暖宫温胞改善卵巢功能异常的机制分析[J].医学信息,2022,35(11):172.[doi:10.3969/j.issn.1006-1959.2022.11.046]
　LUO Hong-cai,SHEN Ying,HUANG Li-shan,et al.The Mechanism Analysis of Improve Symptoms Related to Ovarian Dysfunction Based on Warming Kidney and Helping Yang,Warming Baogong[J].Medical Information,2022,35(18):172.[doi:10.3969/j.issn.1006-1959.2022.11.046]
[10]陈 丽,郝丽娟.多囊卵巢综合征患者腹型肥胖、高雄、胰岛素抵抗及脂代谢的相关性分析[J].医学信息,2022,35(12):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
　CHEN Li,HAO Li-juan.Correlation of Abdominal Obesity, Hyperandrogenism, Insulin Resistance and Lipid Metabolism in Patients with Polycystic Ovary Syndrome[J].Medical Information,2022,35(18):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
[11]袁 奔,潘 伟,罗淑红,等.体重指数对多囊卵巢综合征患者 人工授精妊娠结局影响[J].医学信息,2018,31(12):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
　YUAN Ben,PAN Wei,LUO Shu-hong,et al.Effects of Body Mass Index on the Outcome of Artificial Insemination in Patients with Polycystic Ovary Syndrome[J].Medical Information,2018,31(18):99.[doi:10.3969/j.issn.1006-1959.2018.12.030]
[12]李德君,李慧君.来曲唑联合苍附导痰汤治疗多囊卵巢综合征不孕症患者的 临床观察[J].医学信息,2018,31(17):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]
　LI De-jun,LI Hui-jun.Clinical Observation of Letrozole Combined with Cangfu Daotan Decoction in the Treatment of Infertility Patients with Polycystic Ovary Syndrome[J].Medical Information,2018,31(18):137.[doi:10.3969/j.issn.1006-1959.2018.17.043]

更新日期/Last Update: 1900-01-01